Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

This study has been withdrawn prior to enrollment.
(Funding source was terminated before enrollment of first subject)
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01312493
First received: March 8, 2011
Last updated: May 22, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)